Why Clinical Strategy Matters More Than Rebates with Rich Wipperfurth
カートのアイテムが多すぎます
カートに追加できませんでした。
ウィッシュリストに追加できませんでした。
ほしい物リストの削除に失敗しました。
ポッドキャストのフォローに失敗しました
ポッドキャストのフォロー解除に失敗しました
Why Clinical Strategy Matters More Than Rebates with Rich Wipperfurth
-
ナレーター：
-
著者：
Matt Naylor is joined by Rich Wipperfurth, Chief Growth Officer at WelldyneRX, to discuss his unconventional journey from county social worker to healthcare executive and how that experience shaped his passion for improving patient outcomes. Rich shares why alignment, transparency, and clinical integrity are essential to the future of pharmacy benefit management, how Welldyne is challenging industry norms through innovation and technology, and why partnerships focused on lowering total healthcare costs ultimately benefit patients, employers, and plan sponsors alike. The conversation also explores the evolving regulatory landscape, the importance of measuring total cost over rebates, and what the future holds for transparent, patient-centered pharmacy benefits.